Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Autoimmune Disorders

Free Subscription 02.09.2019 1 Am J Kidney Dis 1 BMC Neurol 1 Curr Opin Immunol 3 Diabetes 1 Intern Med 1 J Autoimmun 2 J Immunol 1 J Neuroimmunol 2 Kidney Int 7 Mult Scler 2 N Engl J Med 4 Neurology 4 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Kidney Dis

1. WEINMANN-MENKE J, Holtz S, Sollinger D, Dorken M, et al
   Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
   Am J Kidney Dis. 2019 Aug 23. pii: S0272-6386(19)30843.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

2. YSRRAELIT MC, Fiol MP, Pena FV, Vanotti S, et al
   Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis.
   BMC Neurol. 2019;19:209.
   PubMed     Text format     Abstract available
   
   

   
   Curr Opin Immunol

3. THI CUC B, Pohar J, Fillatreau S
   Understanding regulatory B cells in autoimmune diseases: the case of multiple sclerosis.
   Curr Opin Immunol. 2019;61:26-32.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes

4. 
   In This Issue of Diabetes.
   Diabetes. 2019;68:469-470.
   PubMed     Text format    
   
   
5. LAM CJ, Chatterjee A, Shen E, Cox AR, et al
   Low Level Insulin Content Within Abundant Non-Beta Islet Endocrine Cells in Long-Standing Type 1 Diabetes.
   Diabetes. 2018 Dec 14. pii: db18-0305. doi: 10.2337/db18-0305.
   PubMed     Text format     Abstract available
   
   
6. KAWABATA Y, Nishida N, Awata T, Kawasaki E, et al
   A genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in CSAD/lnc-ITGB7-1 on Chromosome 12q13.13 Associated with Susceptibility to Fulminant Type 1 Diabetes.
   Diabetes. 2018 Dec 14. pii: db18-0314. doi: 10.2337/db18-0314.
   PubMed     Text format     Abstract available
   
   

   
   Intern Med

7. SHIMA A, Hamaguchi T, Tada Y, Yamada M, et al
   Treatment with Rituximab in the Acute Phase of Relapsing Remitting Multiple Sclerosis: A Case Report.
   Intern Med. 2019 Aug 28. doi: 10.2169/internalmedicine.3408.
   PubMed     Text format     Abstract available
   
   

   
   J Autoimmun

8. NEZOS A, Evangelopoulos ME, Mavragani CP
   Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.
   J Autoimmun. 2019 Aug 20:102317. doi: 10.1016/j.jaut.2019.102317.
   PubMed     Text format     Abstract available
   
   

   
   J Immunol

9. ENGLER JB, Heckmann NF, Jager J, Gold SM, et al
   Pregnancy Enables Expansion of Disease-Specific Regulatory T Cells in an Animal Model of Multiple Sclerosis.
   J Immunol. 2019 Aug 23. pii: jimmunol.1900611. doi: 10.4049/jimmunol.1900611.
   PubMed     Text format     Abstract available
   
   
10. COLAMATTEO A, Maggioli E, Azevedo Loiola R, Hamid Sheikh M, et al
    Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients.
    J Immunol. 2019 Aug 28. pii: jimmunol.1801683. doi: 10.4049/jimmunol.1801683.
    PubMed     Text format     Abstract available
    
    

    
    J Neuroimmunol

11. BASNYAT P, Sumelahti ML, Lehtimaki T, Elovaara I, et al
    Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.
    J Neuroimmunol. 2019;335:577020.
    PubMed     Text format     Abstract available
    
    

    
    Kidney Int

12. ARAUJO SA, Neves PDMM, Wanderley DC, Reis MAD, et al
    The immunohistological profile of membranous nephropathy associated with chronic Schistosoma mansoni infection reveals a glomerulopathy with primary features.
    Kidney Int. 2019;96:793-794.
    PubMed     Text format    
    
    
13. GAN PY, Chan A, Ooi JD, Dick J, et al
    Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis.
    Kidney Int. 2019 May 27. pii: S0085-2538(19)30531.
    PubMed     Text format     Abstract available
    
    

    
    Mult Scler

14. BARIN L, Kamm CP, Salmen A, Dressel H, et al
    How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.
    Mult Scler. 2019 Jan 18:1352458518823955. doi: 10.1177/1352458518823955.
    PubMed     Text format     Abstract available
    
    
15. WEBER E, Goverover Y, DeLuca J
    Beyond cognitive dysfunction: Relevance of ecological validity of neuropsychological tests in multiple sclerosis.
    Mult Scler. 2019;25:1412-1419.
    PubMed     Text format     Abstract available
    
    
16. BRANDSTADTER R, Katz Sand I, Sumowski JF
    Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis.
    Mult Scler. 2019;25:1372-1378.
    PubMed     Text format     Abstract available
    
    
17. GALAZKA G, Mycko MP, Selmaj I, Raine CS, et al
    Multiple sclerosis: Serum-derived exosomes express myelin proteins.
    Mult Scler. 2017 Feb 1:1352458517696597. doi: 10.1177/1352458517696597.
    PubMed     Text format     Abstract available
    
    
18. RANGANATHAN U, Kaunzner U, Foster S, Vartanian T, et al
    Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.
    Mult Scler. 2017 Mar 1:1352458517699876. doi: 10.1177/1352458517699876.
    PubMed     Text format     Abstract available
    
    
19. ROCCA MA, Valsasina P, Leavitt VM, Rodegher M, et al
    Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment.
    Mult Scler. 2017 Mar 1:1352458517699875. doi: 10.1177/1352458517699875.
    PubMed     Text format     Abstract available
    
    
20. LEURS CE, Podlesniy P, Trullas R, Balk L, et al
    Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.
    Mult Scler. 2017 Mar 1:1352458517699874. doi: 10.1177/1352458517699874.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

21. HEROLD KC, Bundy BN, Long SA, Bluestone JA, et al
    An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.
    N Engl J Med. 2019 Jun 9. doi: 10.1056/NEJMoa1902226.
    PubMed     Text format     Abstract available
    
    
22. PITTOCK SJ, Berthele A, Fujihara K, Kim HJ, et al
    Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2019;381:614-625.
    PubMed     Text format     Abstract available
    
    

    
    Neurology

23. FAREZ MF, Correale J, Armstrong MJ, Rae-Grant A, et al
    Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2019 Aug 28. pii: WNL.0000000000008157.
    PubMed     Text format     Abstract available
    
    
24. 
    Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG.
    Neurology. 2019 Aug 29. pii: WNL.0000000000008232.
    PubMed     Text format    
    
    
25. BAHEERATHAN A, McNamara C, Kalam S, Rane N, et al
    The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.
    Neurology. 2018;91:572-573.
    PubMed     Text format    
    
    
26. MAHLER C, Unterrainer M, Muth C, Egensperger R, et al
    Imaging microglial activation in tacrolimus-associated CNS vasculitis with translocator protein PET.
    Neurology. 2018;91:936-937.
    PubMed     Text format    
    
    

    
    Proc Natl Acad Sci U S A

27. RUPRECHT K, Mayer J
    On the origin of a pathogenic HERV-W envelope protein present in multiple sclerosis lesions.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1911703116.
    PubMed     Text format    
    
    
28. KREMER D, Perron H, Kury P
    Reply to Ruprecht and Mayer: Unearthing genomic fossils in the pathogenesis of multiple sclerosis.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1912315116.
    PubMed     Text format    
    
    
29. CHANG C, Loo CS, Zhao X, Solt LA, et al
    The nuclear receptor REV-ERBalpha modulates Th17 cell-mediated autoimmune disease.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1907563116.
    PubMed     Text format     Abstract available
    
    
30. ASHOURI JF, Hsu LY, Yu S, Rychkov D, et al
    Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1904271116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: